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Available online 7 March 2016Dendritic cells (DC) aremononuclear phagocytes which exhibit a branching (dendritic)morphology and excel at
naïve T cell activation. DC encompass several subsets initially identiﬁed by their expression of cell surface mole-
cules and later shown to possess distinct functions. DC subset differentiation is orchestrated by transcription fac-
tors, growth factors and cytokines. Identifying DC subsets is challenging as very few cell surface molecules are
uniquely expressed on any one of these cell populations. There is no standard consensus to identifymononuclear
phagocyte subsets; varying antigens are employed depending on the tissue and animal species studied and be-
tween laboratories. This has led to confusion in how to accurately deﬁne and classify DCs across tissues and be-
tween species. Herewe report a comparative genomics strategy that enables universal deﬁnition of DC and other
mononuclear phagocyte subsets across species. We performed a meta-analysis of several public datasets of
human and mouse mononuclear phagocyte subsets isolated from blood, spleen, skin or cutaneous lymph
nodes, including by using a novel and user friendly software, BubbleGUM, which generates and integrates
gene signatures for high throughput gene set enrichment analysis. This analysis demonstrates the equivalence
between human and mouse skin XCR1+ DCs, and between mouse and human Langerhans cells.
© 2016 The Authors. Published by Elsevier B.V. This is an open access article under the CC BY license
(http://creativecommons.org/licenses/by/4.0/).Keywords:
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Bioinformatics1. Introduction
Mononuclear phagocytes (MPs) comprise dendritic cells (DCs),
monocytes (Mo) and macrophages (Mac). They are critical regulators
of immunity, tolerance and tissue homeostasis (Guilliams et al., 2014).migratory dendritic cells; DC,
mal mononuclear phagocytes;
lysis; LCs, Langerhans cells; LT-
acrophages; Mo, monocytes;
clear phagocytes; NES, normal-
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. This is an open access article underThey populate awide range of tissues and function as immune sentinels
particularly in barrier sites such as skin, gut and lung. A thorough under-
standing of their development and functions is crucial to enable their
manipulation for innovating immunotherapeutic and vaccination
strategies.
Studies in bothmouse and human have provided signiﬁcant insights
into MP biology; fundamentally in relation to the distinct developmen-
tal pathways and functional specializations of DC,monocyte andmacro-
phage subsets (Dutertre et al., 2014b; Reynolds and Haniffa, 2015; Vu
Manh et al., 2015a). However, the lack of a standardized deﬁnition of
MP populations applicable across both tissues and species remains a
pervasive challenge that hampers progress in the ﬁeld (Guilliams
et al., 2014). The historical deﬁnitions of MP populations based on
morphology have been supplemented by surface antigen expression
analysis, which over the years has undergone numerous reﬁnements.
Researchers have utilized a variety of antigen combinations andﬂow cy-
tometry gating strategies to analyze MPs in different tissue and species.
However, the complexity and diversity of markers used to identify
subpopulations of DCs, monocytes or macrophages have prevented
easy extrapolation and interpretation of published data.the CC BY license (http://creativecommons.org/licenses/by/4.0/).
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biology has enabled homologous populations to be identiﬁed across
tissues and species (Contreras et al., 2010; Cros et al., 2010; Crozat
et al., 2010b, 2011; Dutertre et al., 2014a; Gautier et al., 2012; Haniffa
et al., 2012; Ingersoll et al., 2010; Marquet et al., 2014; McGovern
et al., 2014; Miller et al., 2012; Reynolds and Haniffa, 2015; Robbins
et al., 2008; Schlitzer et al., 2013; Segura et al., 2013; Tamoutounour
et al., 2013; Vu Manh et al., 2014, 2015a, 2015b). However, despite
the success of this strategy, non-standardized protocols to deﬁne cell
populations a priori for transcriptome analysis raise questions on the
comparability of ﬁndings presented between groups (Guilliams et al.,
2014; Vu Manh et al., 2015a). A case in point relates to the antigens
and ﬂow cytometry gating strategies used to deﬁne dermal cross-
presenting CD141highXCR1+ DCs in order to investigate their relation-
ship to blood CD141highXCR1+ DCs and to epidermal Langerhans cells
(LCs) in human. Three research groups described CD141+/high DCs in
the human dermis using variable ﬂow cytometry gating strategies
which resulted in three distinct populations with different tran-
scriptome proﬁles and functions (Artyomov et al., 2015; Chu et al.,
2012; Haniffa et al., 2012). These contrasting ﬁndings have created con-
fusion in the ﬁeld on the identiﬁcation of human dermal CD141+/high
DCs, their functions and their homology to mouse MP subsets
(Artyomov et al., 2015; Chu et al., 2012; Haniffa et al., 2012).
In this report, we demonstrate the utility of the novel BubbleGUM
software (Spinelli et al., 2015), with high throughput and automated
Gene Set Enrichment Analysis (GSEA) capabilities, to integrate mi-
croarray transcriptome datasets by generating gene signatures for
distinct MP populations from different tissues and species for
cross-comparison and identiﬁcation of homologies. Using this soft-
ware, as well as complementary methods including principal com-
ponent analysis (PCA) and hierarchical clustering, we reconciled
the inconsistencies between previous analyses of human dermal
CD141+/high DCs. We demonstrate that bona ﬁde human dermal
CD141highXCR1+ DCs are transcriptionally similar to human blood
CD141highXCR1+ DCs and are homologous to murine dermal
CD103+XCR1+ DCs. We also conﬁrm that human LCs are homolo-
gous to murine LCs.
2. Materials and methods
2.1. Microarray expression data
All the microarray data used in the study were obtained from GEO
database. Two datasets were used for mouse cell types and three
datasets were used for human cell types (Fig. 1), to match as well as
possible between tissues and species the diversity of the cell types stud-
ied. Within each species, we ensured having at least one cell type in
common between the different datasets used, to enable cross-
normalization and dataset effect correction. Moreover, we deﬁned cell
type-speciﬁc gene signatures in a consistent way, by comparing the
cell type of interest to a set of reference cell populations that was equiv-
alent across tissues and species. The mouse dataset “a” was generated
by the Immgen consortium (GEO series identiﬁcation number
GSE15907). The mouse dataset “b” was generated by the Malissen
laboratory (GSE49358, GSE65309 and GSE74276). Human datasets “A”
and “C” were generated by the Ginhoux laboratory from blood and
skinMPs (GSE35457 and GSE60317, respectively). Dataset “B”was gen-
erated by the Klechevsky laboratory from skin MPs (GSE66355). All of
these data have been analyzed in previous publications, GSE15907
(Elpek et al., 2011; Gautier et al., 2012; Heng et al., 2008; Miller et al.,
2012), GSE49358 (Tamoutounour et al., 2013), GSE65309 (Terhorst
et al., 2015), GSE35457 (Haniffa et al., 2012), GSE60317 (McGovern
et al., 2014), GSE66355 (Artyomov et al., 2015), except for a subgroup
of mouse dataset b (GSE74276). The list of microarray samples used,
their GEO identiﬁcation numbers and associatedmetadata are provided
in supplementary ﬁle 1. The expression matrices for the differentanalyses performed in this study are available in GEO under the acces-
sion number GSE74316.
2.2. Generation of the microarray compendia and their analyses by PCA or
hierarchical clustering
Themethodological procedure for the preprocessing of the different
microarray datasets used in the study for meta-analysis is described in
Fig. 1.
The mouse Gene 1.0 ST CEL ﬁles were processed through
Bioconductor in the R statistical environment (version 3.0.2). Quality
control of the array hybridization (NUSE plot) and normalization of
the raw Affymetrix expression data with Robust Multi-chip Analysis
(Irizarry et al., 2003) were performed using the oligo package. PCA
was performed using ade4 package to remove the dataset effect visible
on the ﬁrst principal component (Fig. S1A–B). The two mouse datasets
included in common epidermal LCs, blood classical monocytes (cMo),
cutaneous lymph node (CLN) CD11b+ migratory DCs (migDCs) and
CLN plasmacytoid DCs (pDCs). For each of these control cell popula-
tions, the samples from the two datasets regrouped well together in
the PCA or hierarchical clustering analyses after merging and correction
of the dataset effect. Similar expression patterns were observed within
each mouse dataset before and after data merging, quantile cross-
normalization and dataset effect removal, when examining 52 control
genes encoding key lineage-speciﬁc transcription factors, innate im-
mune recognition receptors or signaling molecules (Fig. S1C–D). This
validated the adequacy of data preprocessing to prevent artefactual
changes in the relative gene expression between cell populations or
datasets.
The Illumina Human WG-6 v3 and Illumina Human HT12 v4.0 raw
data ﬁles were processed through Bioconductor in the R statistical envi-
ronment (version 3.0.2). Gene expression signals from GSE60317
(Haniffa et al., 2012) and GSE35457 (McGovern et al., 2014) were
merged using common probes. Quantile Normalization (Bolstad et al.,
2004) was applied on the merged expression arrays using the lumi
package, prior to log2-transformation of expression values. Gene ex-
pression signals from GSE66355 were already background corrected
and quantile normalized (Artyomov et al., 2015). Noise threshold was
estimated at ﬁve based on the density of all gene expression signals.
All values less than ﬁve were replaced by this noise threshold. Expres-
sion values were log2-transformed to enable comparison with the
other two humanmicroarray datasets. The three datasets were merged
using common probes and quantile normalized. PCA was performed to
remove the dataset effect visible on the ﬁrst two principal components
(Figs. S2, S3 and S4). CD14+ dermal MPs (CD14+_DMPs) was a com-
mon population encompassed in all three datasets. In addition, both
datasets B and C contained epidermal LCs. LC samples regrouped to-
gether in PCA or hierarchical clustering after the datasets were merged
and corrected. This was also the case for CD14+_DMPs from datasets B
and C but the CD14+_DMPs from dataset A wasmore distant. However,
when examining individual gene contributions to PCA axes on the
merged datasets before correction (Fig. S2B–D), the vast majority of
transcripts accounting for the differences between datasets according
to PC1 and PC2 did not contribute signiﬁcantly to differences between
MP subsets according to PC3 and PC4. Many genes known as selectively
expressed by, or affecting the biology of, MP subsets were strong con-
tributors to PC4 but had only a weak contribution to PC1 (Fig. S2D). In
contrast, the vast majority of the transcripts strongly contributing to
PC1 were not known to affect the identity or biology of MP subsets,
and were not differentially expressed between subsets of DCs or mono-
cytes/macrophages within each dataset (Fig. S3). Careful scrutiny of the
expression patterns of 68 genes encoding key lineage-speciﬁc transcrip-
tion factors, innate immune recognition receptors or signalingmolecules
within each human dataset before and after data merging, quantile
cross-normalization, and dataset effect correction revealed no obvious
biases or artifacts from data pre-processing (Fig. S4). In particular,
Fig. 1. Overall scheme for the generation and analysis of datasets. Outline of pre-processing pipeline for the meta-analysis of the different mouse and human datasets analyzed.
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monocyte/macrophage genes and low levels of genes speciﬁc to other
cell lineages, before and after data processing. Hence, data preprocessing
was adequate and did not cause artefactual changes in the relative gene
expression proﬁling between cell populations or datasets which could
confound the subsequent analyses and their interpretation.
Human and Mouse datasets were then merged into a single matrix
of orthologous genes identiﬁed using the Ensembl BioMart software
with selection of “one-to-one” orthology relationships only (13,371
unique genes). Agglomerative hierarchical clustering (using Hmisc
and cluster packages) and PCA (using ade4 R package) were performed
on the merged human and mouse matrix. We used distinct distance
metric/linkage parameters to generate several agglomerative hierarchi-
cal clustering trees, because this approach can reveal distinct similarity
patterns in the data.
2.3. Generation of gene signatures and high throughput GSEA using
BubbleGUM
The BubbleGUM software (Spinelli et al., 2015) was used to gen-
erate MP subset-speciﬁc transcriptomic signatures from speciﬁc
datasets and to assess their enrichment across cell types from
other datasets. BubbleGUM is an open-source software composedof two modules; i) GeneSign, which generates statistically signiﬁ-
cant gene signatures and ii) BubbleMap, which automatically as-
sesses the enrichment of input gene signatures between all
possible pairs of conditions from independent datasets, based on
gene set enrichment analysis (GSEA) methodology (Subramanian
et al., 2005, 2007), and which generates an integrated graphical
display.
Using GeneSign, gene signatures of MP subsets were generated for
each species (human and mouse), i.e. the lists of genes that are more
highly expressed in the MP subsets of interest (test classes) as com-
pared to other MP subsets (reference classes), using the “minimal
pairwise mean” calculation method with a minimal fold change of 1.5
in linear scale and a maximal false discovery rate (FDR) of 0.01. The
test and reference classes of MP subsets chosen to deﬁne each of the
cell type signatures used in the manuscript, as well as the gene content
of these signatures, are provided in supplementary ﬁle 1.
To run BubbleMap, we used in-house signatures of mouse or human
MP subsets devised in GeneSign aswell as a list of over 400 independent
GeneSets from MSigDB (Liberzon, 2014). BubbleMap was used with
1000 geneset-based permutations, and with “difference of classes” as a
metric for ranking the genes since the data were expressed in Log2
scale. The results are displayed as a BubbleMap, where each bubble is a
GSEA result and summarizes the information from the corresponding
38 S. Carpentier et al. / Journal of Immunological Methods 432 (2016) 35–49enrichment plot. The color of the Bubble corresponds to the subset from
the pairwise comparison in which the signature is enriched. The bubble
area is proportional to theGSEAnormalized enrichment score (NES). The
intensity of the color corresponds to the statistical signiﬁcance of the
enrichment, derived by computing the multiple testing-adjusted
permutation-based p-value using the Benjamini–Yekutieli correction.
2.4. Heatmaps
Heatmapswere performedusingGene-E (http://www.broadinstitute.
org/cancer/software/GENE-E/), using the ﬁnal gene expression values
for the human and mouse datasets after merging the various datasets
into a single matrix, with removal of the ﬁrst (or ﬁrst two) principal
component(s) of PCA which generated negative expression values. The
expression values were not centered and reduced, in order to avoid
misrepresenting the relative importance of individual genes by changing
their variance. This allowed retention of genes with high variance in only
one species but not the other. For the same rationale, global scale expres-
sion values were used for graphical output, rather than relative scales ad-
justed for each gene to itsminimal andmaximal expression values across
the entire dataset.
3. Results
3.1. Human and mouse LCs transcriptionally resemble DCs
Within the human compendium (Fig. 2A), LCs regroupedwith blood
DCs in the upper half of PC1 vs PC2, while bloodMo, skinMac (SK_Mac)
and skin CD14+_DMPs (SK_CD14+_DMPs) regrouped together in the
lower right quadrant. Within the mouse compendium (Fig. 2B), LCs
also regrouped with DCs, in the lower left quadrant of PC1 vs PC2,
while blood and skin monocytes regrouped with skin macrophages
and monocyte-derived DCs (MoDCs), in the upper right quadrant. For
hierarchical clustering, various parameters were used for distance cal-
culation to generate several trees revealing distinct similarity patterns
in the data. In most hierarchical clustering analyses, mouse and
human LCs regrouped with subsets of cDCs and were excluded of the
branch of the tree encompassing all monocytes or monocyte-derived
cells (Fig. 3A). In the hierarchical clustering analyses where mouse
and human LCs did not regroup together, they were still associated
with subsets of cDCs and not with monocytes or monocyte-derived
cells (Fig. 3B).
High throughput GSEA performed using our BubbleGUM software
(Spinelli et al., 2015) showed that, when compared to each of the pop-
ulations of monocytes or monocyte-derived cells, mouse and human
LCs were enriched for the genes more highly expressed in DCs com-
pared to monocytes/macrophages (DC_vs_Mo/Mac gene signatures)
(Fig. 4,❶,❺, blue boxes). Conversely, the reciprocal Mo/Mac_vs_DC
gene signatures were enriched in each of the populations of mouse or
human monocytes or monocyte-derived cells analyzed when they
were compared to LCs (Fig. 4,❶,❺, red boxes). Expression proﬁles of
genes contributing to these GSEA patterns are depicted as heatmaps of
genes with higher expression in cDCs and LCs (Fig. 5A) and of genes
with higher expression in monocytes and monocyte-derived cells
(Fig. 5B).
3.2. Human and mouse LCs are homologous and express common gene
signatures
Human and mouse LCs on the one hand, and mouse and human
pDCs on the other hand, regrouped together within the merged
human/mouse compendia by PCA, on the PC1 versus PC2 representa-
tion (15.1% versus 9.7% variability, respectively) (Fig. 2C). The use of dif-
ferent linkage methodologies for hierarchical clustering revealed
distinct similarity patterns in the data, since human and mouse LCs
but not mouse and human pDCs clustered together in most instances(Fig. 3A), whereas the reverse was observed in other instances
(Fig. 3B), consistent with the observation that human and mouse
pDCs were separated on the PC3 axis (8.1% variability) and mouse and
human LCs on the PC4 axis (5.4%) of the PCA (Fig. 2C). Mouse LCs
were signiﬁcantly enriched for the human LC gene signature by GSEA
(Fig. 4, ❶, black box). This enrichment does not reach signiﬁcance
only for the comparison with CLN migratory cDC subsets. Genes selec-
tively expressed in bothmouse andhuman LCs are shown as a heatmap,
including genes that were used to deﬁne LCs in human and/or mouse
(CD207, EPCAM), selectively expressed in human LCs compared to
other skin MP subsets (Polak et al., 2014), or regulating LC functions
(ABCC4 and BMPR1A) (van de Ven et al., 2008; Yasmin et al., 2013)
(Fig. 5C).
These analyses show that, contrary to what was recently reported
(Artyomov et al., 2015), human LCs do not display a greater similarity
to the mouse XCR1+ DCs than to mouse LCs. Rather, human and
mouse LCs are homologous and express a common gene signature.
3.3. The identiﬁcation of bona ﬁde human CD141highXCR1+ dermal DCs is
challenging
A dermal DC subset homologous to human blood CD141highXCR1+
DCs has been identiﬁed in the human dermis and shown to be very ef-
ﬁcient at antigen cross-presentation similar to their murine counter-
parts (Haniffa et al., 2012). Other teams have studied human dermal
CD141+ DCs but reported different functional properties and homology
relationships (Artyomov et al., 2015; Chu et al., 2012). A recent report
claimed that human LCs and not SK_CD141+_DDCs were equivalent
to human blood CD141highXCR1+ DCs and to mouse XCR1+ DDCs
(Artyomov et al., 2015). As CD141 is promiscuously expressed on vari-
ous MP subsets (Crozat et al., 2010a; Haniffa et al., 2012; McGovern
et al., 2014; VuManh et al., 2015a), we wondered whether the discrep-
ancies existing in the literature on the functions of dermal CD141high/+
DCs could be due to variations in the ﬂow cytometry gating strategies
used to identify these cells resulting in different CD141+/high popula-
tions being studied. The CD141+ DCs isolated by Chu et al. expressed
the monocyte marker CD14 and corresponded to CD14+ dermal
monocyte-derived macrophages (McGovern et al., 2014). The identity
of the CD141+ dermal cells studied by Artyomov et al. was less obvious,
although they were CD14− and CD1alow and stained with an anti-XCR1
antibody. Interestingly, the three isolation strategies resulted in dermal
CD141+/high DCs with contrasting transcriptome proﬁles.
In order to further assess the identity and lineage relationships of the
two reported dermal CD141high/+ DCs, we reanalyzed the human DC,
monocyte and macrophage microarray compendia associated with
these studies (Artyomov et al., 2015; Haniffa et al., 2012; McGovern
et al., 2014). Of note, all three datasets included CD14+_DMPs, and
LCs were shared between the Artyomov and McGovern datasets,
allowing to control dataset compatibility as discussed in Section 2. The
SK_CD14+_DMPs shared similar transcriptomic characteristics even
though differences linked to datasets of origin existed. In PCA and hier-
archical clustering, human epidermal LCs (SK_LCs) regrouped together
irrespective of their dataset of origin (Figs. 2 and 3). In contrast, striking-
ly, the two sets of skin CD141+/high_DDCs from Haniffa et al., and
Artyomov et al., clustered in very different areas by PCA (Fig. 2A-B)
and hierarchical clustering (Fig. 3A-B). By PCA, SK_CD141high_DDCs_A
from the pioneering publication which reported their discovery
(Haniffa et al., 2012) were close to SK_CD1c+_DDCs and distant from
SK_CD14+_DMPs, while the converse was observed for the
SK_CD141+_DDCs_B described in the publication which reported lack
of close homology of these cells with human BD_CD141high_DCs and
mouse XCR1+ DCs (Artyomov et al., 2015). By hierarchical clustering
(Fig. 3), the SK_CD141+_DDCs_B clustered together with mouse
SK_MoDCs. These observations strongly suggested that the SK_CD141-
high_DDCs_A were related to DCs, whereas the SK_CD141+_DDCs_B
were a subset of monocyte-derived cells.
Fig. 2. Relationships betweenMP subsets by PCA. Principal component analysis of humanMP subsets (A), mouseMP subsets (B) andmerged human andmouseMP subsets (C). Numbers
in parenthesis indicate the percentage variability of the dataset along each PC axis.
39S. Carpentier et al. / Journal of Immunological Methods 432 (2016) 35–49We next performed GSEA to compare human CD141high/+ DCs and
mouse XCR1+ DCs. The gene signature of the human SK_CD141high_DDC_A
was signiﬁcantly enriched in the mouse CLN_XCR1+_migDCs
(Fig. 4A, ❸, green box). Reciprocally, the gene signature of the
mouse CLN_XCR1+_migDCs was signiﬁcantly enriched in human
SK_CD141high_DDCs_A (Fig. 4B,❼, green box). In contrast, the genesignature of human SK_CD141+_DDC_B was not signiﬁcantly enriched
in any of the mouse DC subsets examined (not shown). In addition,
the human SK_CD141+_DDCs_B were not signiﬁcantly enriched for
the gene signature of the mouse CLN_XCR1+_migDCs when compared
to any of the other 11 human cell subsets studied (Fig. 4B,❽, orange
box). In contrast to human SK_CD141high_DDCs_Awhichwere enriched
Fig. 3. Relationships between MP subsets by hierarchical clustering. (A) Pearson correlation distance and Ward's method linkage. (B) Pearson correlation distance and average linkage.
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SK_CD141+_DDCs_B were enriched for the mouse Mo/Mac_vs_DC sig-
natures when compared to all previously characterized human skin or
blood DC subsets, including SK_CD141high_DDCs_A, BD_CD141high_DCs,
BD_pDCs, BD_CD1c+_DCs and SK_LC (Fig. 4B,❽, brown box). Compar-
ing SK_CD141high_DDCs_A and SK_CD141+_DDCs_B individually
against all other human MP subsets revealed the striking difference
between these two populations (orange box, Fig. 4B). This highlights
the major drawback of a priori population deﬁnition using different
ﬂow cytometry gating strategies.
Genes contributing to the GSEA proﬁles from the human andmouse
compendia are shown as heatmaps (Fig. 5). Genes more highly
expressed in cDCs include hallmark genes of mature DCs (CCR7, RELB,
FASCIN1, IL4I1, MARCKSL1) (Dalod et al., 2014; Miller et al., 2012; Vu
Manh et al., 2013) which were also highly expressed in SK_CD141-
high_DDCs_A over Mo/Mac and SK_CD141+_DDCs_B (Fig. 5A). This is
in contrast to SK_CD141+_DDCs_B, which expressed genes characteris-
tic ofMo/Mac and/or regulating their development (CEBPB,MAFB, CD14,
TLR4, SLC11A1) (Cain et al., 2013; Gautier et al., 2012; Kelly et al., 2000;
Wyllie et al., 2002) (Fig. 5B). Genes highly expressed commonly in
human SK_CD141high_DDCs_A and mouse CLN_XCR1+_migDCs orFig. 4. Analysis of the homologies between human andmouse MP subsets by high throughput G
were generated using GeneSign separately for the mouse and human compendia. These signa
comparisons between MP subsets of the other species using the BubbleMap module of Bu
signiﬁcant enrichment, in a color matching that of the condition in which the GeneSet was en
of each ﬁgure, red for the populations to which the comparison is performed). The strength o
expression intensity of the genes enriched. The signiﬁcance of the enrichment is measured by
of the GeneSetwas a false-positive ﬁnding (e.g., if q= 0.25, a similar enrichment is found in 25%
testing, leading to a higher stringency of the signiﬁcance threshold used. The absolute NES valu
richment is considered signiﬁcant for absolute NES values N1with an associated q value b0.25. (
signatures assessed for enrichment across human MP subsets.mouse XCR1+_LT-DCs encompassed many genes previously reported to
be characteristic of this cross-presenting DC subset (BTLA, CADM1,
CXCL9, GCET2, IL12B, SNX22 and TLR3) (Alexandre et al., 2016; Balan
et al., 2014; Dutertre et al., 2014a; Galibert et al., 2005; Haniffa et al.,
2012; Lee et al., 2015; Meixlsperger et al., 2013; Poulin et al., 2010;
Robbins et al., 2008; Shortman and Heath, 2010; Vu Manh et al., 2015a,
2015b) (Fig. 5D). Notably, a number of these genes were strongly down-
regulated inmouse CLN_XCR1+_migDCs as previously reported, as a con-
sequence of theirmaturation (Crozat et al., 2011; VuManh et al., 2013) or
of their imprinting by the skinmicroenvironment. A similar downregula-
tion of the canonical gene signature of the cross-presentingDC subsetwas
also observed in human SK_CD141high_DDC_A (Fig. 5D, see for example
CADM1, CLNK and TLR3, and data not shown). This may have contributed
to make their rigorous identiﬁcation more difﬁcult.
For each known pair of homologous mouse and humanMP subset, a
very strong, speciﬁc and signiﬁcant enrichment of the corresponding
gene signatures fromone specieswas also observed in the other species,
providing excellent positive and negative controls for the BubbleGUM
analysis. These included the enrichment of the following gene signa-
tures: human BD_CD141high_DC in mouse CLN_XCR1+_LT_DC (Fig. 4,
❷), human SK_CD14+_DMP and SK_Mac in mouse SK_Mac (Fig. 4,SEA using BubbleGUM. Gene signatures speciﬁc to each subset of MPs, or their subgroups,
tures obtained in one species were then assessed for enrichment in all possible pairwise
bbleGUM. Data are represented as Bubbles, bigger and darker for stronger and more
riched (blue for the population indicated in blue characters on the annotation on the left
f the enrichment is quantiﬁed by the NES which represents the number and differential
the false discovery rate (FDR) value (q) representing the likelihood that the enrichment
of the randomGeneSets used as controls). This q-valuewas further corrected formultiple
es generally vary between 1 (no enrichment) and 5 (extremely high enrichment). The en-
A)HumanMP signatures assessed for enrichment acrossmouseMP subsets. (B)MouseMP
41S. Carpentier et al. / Journal of Immunological Methods 432 (2016) 35–49❹), mouse Mo/Mac_vs_DC and SP_RPM in human SK_CD14+_DMPs
(Fig. 4,❾), human pDC in mouse pDCs (Fig. S5A,❶) and reciprocally
mouse pDC in human pDCs (Fig. S5B, ❺). Furthermore, usingBubbleGUM, we conﬁrmed previous reports of homology between
human and mouse monocytes subsets (Fig. S5, ❸, ❹, ❽, ❾) (Cros
et al., 2010; Ingersoll et al., 2010; Vu Manh et al., 2015b).
42 S. Carpentier et al. / Journal of Immunological Methods 432 (2016) 35–49In order to identify the tissue equivalents of blood CD141high DCs,we
generated gene signatures of human blood MP subsets and analyzed
their enrichment across human skinMP subsets (Fig. 6). This conﬁrmedour prediction that only SK_CD141high_DDCs_A but not SK_CD141+_-
DDCs_B were the tissue equivalent of blood CD141high_DCs (Fig. 6A,
❸, green box). SK_CD141high_DDCs_A and SK_CD141+_DDCs_B were
43S. Carpentier et al. / Journal of Immunological Methods 432 (2016) 35–49enriched with gene signatures from distinct blood MP populations (or-
ange box, Fig. 6A) providing further support of their distinct identities.
The humanBD_CD141high_DC gene signaturewas signiﬁcantly enriched
in the human SK_CD141high_DDC_A when compared to each of the
other human skin MP subsets examined, including SK_LCs and
SK_CD141+_DDC_B (Fig. 6A; ❸, green box), as previously reported
using the CMAP method (Haniffa et al., 2012). In contrast, none of
the human blood MP signature was consistently enriched in
SK_CD141+_DDC_B when compared to all other human skin MP sub-
sets (Fig. 6A,❹). Similarly, when analyzing across human blood cell
subsets the expression of the gene signatures of human skin cell subsets,
the SK_CD141high_DDC_A signature was signiﬁcantly enriched in the
human BD_CD141high_DC (Fig. 6B, ❾, green box). In contrast, the
SK_CD141+_DDC_B signature was not found to be signiﬁcantly
enriched in any of the human blood cell subsets examined. Genes selec-
tively expressed in both BD_CD141high_DCs and SK_CD141high_DDC_A
include genes previously reported to be characteristic of this DC subset
in human or mouse, eventually controlling their development or func-
tions (Fig. 6C) (BATF3, CADM1, GCET2, IDO2, RAB7B, ID2, BTLA, STX3,
FAM46C, TAP1, ARHGAP22, RASGPR3) (Galibert et al., 2005; Ginhoux
et al., 2009; Grajales-Reyes et al., 2015; Hacker et al., 2003; Haniffa
et al., 2012; Hildner et al., 2008; Jackson et al., 2011; Jaiswal et al.,
2013; Robbins et al., 2008). A parallel analysis of mouse MP subsets
yielded very similar results (Fig. S6).
3.4. Human bona ﬁde CD141highXCR1+ dermal DCs express MHC-I antigen
(cross)-presentation genes
Upon comparison of the gene expression programs of human SK_LCs
with human SK_CD141+_DDC_B and CD14+_DMPs, it was concluded
that human LCs but not human SK_CD141+_DDC_B are enriched with
MHC-I antigen (cross)-presentation genes (Artyomov et al., 2015). Be-
cause we demonstrated above that the SK_CD141+_DDC_B from
Artyomov et al. and our SK_CD141high_DDC_A correspond to different
cell types, and because of the discrepancies in previous reports compar-
ing cross-presentation functions of human LCs and dermal CD141+/high
DCs (Artyomov et al., 2015; Haniffa et al., 2012), we evaluated the ex-
pression of MHC-I antigen (cross)-presentation genes across the
whole human MP subset compendium studied here (Figs. 7 and S7).
We conﬁrmed that the GeneSets “ER_phagosome_pathway” and
“Cross-presentation of soluble exogenous antigens endosomes” were
signiﬁcantly enriched in human SK_LCs when compared not only to
SK_CD141+_DDC_B (Fig. 7A, ❶, green box) but to all the other
human cell populations examined (Fig. 7A, ❶, blue box) but one
(Fig. 7A,❶, orange box). However, importantly, this unique excep-
tion corresponded to the SK_CD141high_DDC_A. Indeed, both
human LCs (Fig. 7A,❶, blue box) and bona ﬁde human SK_CD141-
high_DDC_A (Fig. 7A,❸) strongly express “ER_phagosome_pathway”
and “Antigen_presentation_folding_assembly_and_peptide_loading_
of_class_I_MHC” genes when compared to other human skin MP sub-
sets. This analysis further illustrated the differences between human
SK_CD141+_DDC_B and SK_CD141high_DDC_A, as demonstrated by
their differential expression of Reactome GeneSets (subpanels❸ and
❹ and orange box in Fig. 7A). To interrogate this further, we generated
a heatmap of MHC-I antigen (cross)-presentation genes for all human
and mouse MP subsets (Fig. 8A). This revealed that most of the MHC-I
antigen (cross)-presentation genes were expressed at higher levels in
LCs and cDCs including SK_CD141high_DDCs_A than in cells derived
from monocytes, which included SK_CD141+_DDCs_B. Whereas manyFig. 5.Heatmaps of selected genes contributing toGSEAproﬁles in Fig. 4. Expression data collapsed
compendia. Each cell type is depicted by the same symbol used in the PCA in Fig. 2, with the name
Mac GeneSet. (B) Genes from the mouse and human Mo/Mac_vs_DC GeneSet. (C) Genes from th
SK_CD141high_DDC_A GeneSets and from the mouse SP_XCR1+_LT-DC and/or CLN_XCR1+_mig
they are selectively expressed are shown in bold red font. Genes for which a selective expressi
human MPs, with results consistent with those shown here, are in bold black font.of these genes were expressed at similar levels in LCs and SK_CD141-
high_DDCs_A, several were higher in SK_CD141high_DDCs_A, including
PSMB5, PSMD10, PSME2, TAP1, B2M, HLA-A, HLA-B and HLA-G.
Hence, among the human MP subsets found in the skin or in the
blood, human LCs do stand apart as expressing high levels of the
genes associated to MHC-I antigen (cross)-presentation, consistent
with similar analyses performed previously (Artyomov et al., 2015).
However, high expression of these genes is not a hallmark of human
LCs alone and also applies to bona ﬁde human skin CD141highXCR1+
DDCs. Nevertheless, the expression pattern of the reactome GeneSets
associated with MHC-I antigen processing/(cross)-presentation was
strikingly similar between human SK_LCs and mouse CLN_XCR1+_-
MigDCs (Fig. 7A,❶ and Fig. 7B,❽; blue boxes). Many of the genes asso-
ciated with MHC-I antigen (cross)-presentation that were selectively
expressed at higher levels by human SK_LCs and SK_CD141high_DDC_A
compared to other human myeloid cell types (Fig. 8A) were also
expressed to high levels in mouse CLN_XCR1+_migDCs but not by
mouse SK_LCs (Fig. 8B), consistent with the differences recently report-
ed between mouse and human LCs (Artyomov et al., 2015).
4. Discussion
Recent reports characterized three different cell populations identi-
ﬁed as dermal ‘CD141+ DCs’ with overlapping phenotypes but each
with unique transcriptome proﬁles, functions, and lineage relationships
to other tissue DCs in humans and mice (Artyomov et al., 2015; Chu
et al., 2012; Haniffa et al., 2012). This discrepency in the literature has
caused confusion in the ﬁeld regarding how best to identify these cells
and deﬁne their precise functions. In this study, we aimed to clarify
these conﬂicting reports and to deﬁnemurine and human skin MP sub-
sets, their intra-species tissue equivalents and inter-species homologs,
using comparative genomics. By exploiting public datasets for MP sub-
sets from blood, spleen, skin or cutaneous lymph node of humans and
mice, we rigorously identiﬁed DC subsets, monocytes andmacrophages
in these tissues and aligned them across species. We showed here that
humandermal CD14+CD141+population (Chu et al., 2012) and dermal
CD1adimCD141+ cells (Artyomov et al., 2015) are related to monocyte-
derived cells and/or macrophages. We also show that the human MP
population equivalent to human blood CD141highXCR1+ DCs are the
bona ﬁde CD141highXCR1+DDCs (Haniffa et al., 2012) and not LCs as re-
cently claimed (Artyomov et al., 2015). This reafﬁrms the homologous
relationships between human andmouse skin XCR1+ DCs and between
human and mouse LCs.
In our analysis, both human andmouse LCs transcriptionally resem-
ble cDCs rather than monocytes or monocyte-derived cells. This ex-
plains the morphologic and functional similarities between LCs and
cDCs supporting the classiﬁcation of LCs as DCs based on gene expres-
sion proﬁling and function (Artyomov et al., 2015). However, in contrast
to cDCs which arise from bonemarrowHSCs, LCs develop from yolk sac
and fetal liver precursors and are thus developmentally related to
tissue-resident macrophages (Hoeffel et al., 2012, 2015). A recent no-
menclature attempted to resolve this issue by proposing that MPs
should be classiﬁed based on a two-stage system: ﬁrstly according to
ontogeny (level one), and secondly based on their function, location
and/or morphology (level two) (Guilliams et al., 2014).
The dichotomy between the developmental and functional attri-
butes of LCs highlights the critical role of the tissue microenvironment
in imprinting subset identities on MPs. From birth, the epidermal envi-
ronment imprints on fetal monocytes a transcriptional program thatto themedian expression across replicates are shown for the human (left) andmouse (right)
of cell types spelled out above the ﬁgure. (A) Genes from themouse and human cDC_vs_Mo/
e mouse and human SK_LC GeneSets. (D) Genes from the human BD_CD141high_DC and/or
DC GeneSets. Genes regulating the development or functions of the MP subset(s) in which
on pattern was previously and independently reported across several subsets of mouse or
Fig. 6. Analysis of the homologies between human blood and skin MP subsets by high throughput GSEA using BubbleGUM. Gene signatures speciﬁc to each subset of human MPs, or to
subgroups of MPs, were generated independently from blood and skin data using GeneSign. The signatures obtained in one tissue were assessed for enrichment in all possible pairwise
comparisons between MP subsets from the other tissue using BubbleMap. Data are represented as in Fig. 4. (A) Human blood MP gene signatures assessed for enrichment across
human skin MP subsets. (B) Human skin MP gene signatures assessed for enrichment across human blood MP subsets. (C) Heatmaps illustrating the expression patterns of selected
genes contributing to the GSEA proﬁles of (A) and (B). Expression data were collapsed to the median expression across replicates within the human compendium. Each cell type is
depicted by the same symbol used in the PCA in Fig. 2, with the name of cell types spelled out above. Genes previously reported to be characteristic of this DC subset in human or
mouse are in bold black font, and genes known to control their development or functions in bold red font.
44 S. Carpentier et al. / Journal of Immunological Methods 432 (2016) 35–49directs the functional convergence of LCs towards DCs. Similar imprint-
ing also occurs in adult murine skin upon inﬂammation where distinct
LC precursors undergo a differentiation program that culminates in a
common end functional phenotype (Chopin et al., 2013; Nagao et al.,
2012; Price et al., 2015; Sere et al., 2012). More recently, a reciprocal
transcriptomic and functional convergence towards LCs of cells origi-
nating from pre-DC was reported, likely resulting from imprinting by
the oral mucosa (Capucha et al., 2015). LC subsets arising from different
progenitors can be distinguished in the sublingualmucosa of mice, with
CD103+CD11blow LCs arising from pre-DCs and CD11b+CD103− LCs
from both pre-DCs and monocytic precursors. It could be argued that
oral mucosal pre-DC-derived LCs should not be called LCs but rather
cDCs due to their ontogeny. However, despite their ontogenic differ-
ences, oral mucosal LCs and epidermal LCs share similar immunological
functions and transcriptomic signature (Capucha et al., 2015). This sup-
ports a signiﬁcant role of peripheral tissue programming in dictating the
ﬁnal outcome of the functional differentiation of a MP population
(Becher et al., 2014; Schlitzer et al., 2015). Peripheral programming en-
sures that each anatomical niche is populated by MPs with appropriate
functions irrespective of their ontogeny. Two recent publications sup-
port this notion by demonstrating epigenetic reprogramming within
macrophages originating from a given tissue upon adoptive transfer
into another tissue (Gosselin et al., 2014; Lavin et al., 2014).Wedemonstrate here that human andmouse LCs express a common
speciﬁc molecular signature and correspond to homologous cell types.
Strikingly, however, while mouse LCs are signiﬁcantly enriched for the
human LC gene signature, the reverse is not true (Fig. 4B, ❺, gray
box). The mouse LC gene signature is signiﬁcantly enriched in human
SK_CD141high_DDC_A and SK_CD1c+_DDC when compared to human
LCs. However, one should note that the mouse LC gene signature en-
compasses almost twice asmany genes (570) as the human LC gene sig-
nature (269). Mouse LCs selectively express many genes whose
expression patterns are not conserved between mouse and human
skin MPs (Fig. S8). This may explain the distinct biological functions
that have been reported between mouse versus human LCs. Mouse
LCs were shown to possess tolerogenic (Flacher et al., 2014; Gomez de
Aguero et al., 2012; Kautz-Neu et al., 2011; Price et al., 2015;
Shklovskaya et al., 2011) rather than immunogenic (Elnekave et al.,
2014) functions (reviewed in Igyarto and Kaplan (2013); Malissen
et al. (2014)). In contrast, human LCs are generally reported to be im-
munogenic (Banchereau et al., 2012; Klechevsky et al., 2008; Romano
et al., 2012) rather than tolerogenic ((Seneschal et al., 2012; van der
Aar et al., 2013); reviewed in Durand and Segura (2015)). Hence,
there may be more differences between mouse and human LCs than
between other homologous subsets of mouse and human MPs, as was
recently proposed (Artyomov et al., 2015). These differences may be
Fig. 7.GSEA of selected ReactomeGeneSets across human andmouseMP subsets. Selected ReactomeGeneSetswere assessed for enrichment in all possible pairwise comparisons between
MP subsets in the human (A) or mouse (B) compendia. Data are represented as in Fig. 4.
45S. Carpentier et al. / Journal of Immunological Methods 432 (2016) 35–49accounted for by external environmental factors since, unlike humans,
mice are housed in speciﬁc pathogen free environment, a condition
which may favor the long-term persistence of prenatal LCs. In mice,inﬂammation can result in partial replenishment of LCs by blood
borne precursors which may have unique features compared to
prenatally-derived LCs (Chopin et al., 2013; Nagao et al., 2012; Price
Fig. 8. Heatmaps illustrating the expression of MHC-I antigen (cross)-presentation genes. Expression data were collapsed to the median expression across replicates within the human
versus mouse compendia. Each cell type is depicted by the same symbol used in the PCA in Fig. 2, with the name of cell types spelled out above.
46 S. Carpentier et al. / Journal of Immunological Methods 432 (2016) 35–49et al., 2015; Sere et al., 2012). In particular, only prenatally-derived LCs
are relatively resistant to irradiation as a consequence of high constitu-
tive expression of the DNA-repair machinery molecule CDKN1A (Price
et al., 2015). It is also possible that murine LCs are functionally adapted
to fur-bearing mice skin compared to human LCs. Alternatively or in
addition, differences in the experimental protocols used for the isolation
of MP subsets from mouse versus human skin may also confoundcomparison of LCs between these 2 species, including differential con-
tamination by other cell types. These differences and heterogeneity
may be difﬁcult to evaluate using bulk-population analysis but could
be explored with single-cell transcriptome proﬁling.
Contrary to what was recently reported (Artyomov et al., 2015),
we showed that the human skin DCs equivalent to human blood
CD141highXCR1+ DCs are bona ﬁde CD141highXCR1+ DDCs and not
47S. Carpentier et al. / Journal of Immunological Methods 432 (2016) 35–49LCs, and we showed that human and mouse LCs are homologous. Why
did our interpretation of the analysis of the gene expression proﬁling
data from these authors differ from their own? The discrepancies be-
tween our report and Artyomov et al. are primarily methodological in
nature. Firstly, the cells isolated as human skin CD141+ DDCs in
Artyomov et al. were not bona ﬁde CD141highXCR1+ DDCs but rather
cells of the monocytic lineage, as we showed through re-analysis of
their transcriptome proﬁle. Secondly, the interpretation by Artyomov
et al. of their gene expression proﬁling data was further confounded
by a suboptimal match for cell type composition between the different
MP datasets used, namely between the human blood versus skin
datasets, and between the mouse versus human skin datasets.
Regarding the nature of the CD141+ DDCs from the human “B”
dataset, rigorous identiﬁcation of bona ﬁde human CD141highXCR1+
dermal DCs is challenging. It requires the use of careful marker combi-
nations for ﬂow cytometry sorting as well as performing a posteriori
analyses to ensure of the identity of the cell type isolated (Vu Manh
et al., 2015a, 2015b). Unfortunately at present, there isn't a single sur-
facemarker thatwill reliably identify bonaﬁdehumanCD141highXCR1+
dermal DCs. CD141 is not unique to these cells but promiscuously
expressed by blood and skin CD1c+ DCs (Haniffa et al., 2012), a fraction
of skin CD14+ cells (Haniffa et al., 2012) andMoDCs (Balan et al., 2014).
Although XCR1 uniquely identiﬁes these cells at mRNA level in the
human, to the best of our knowledge there isn't yet a reliable commer-
cially available antibody against human XCR1. The CD141+ DDCs isolat-
ed by Artyomov et al. stained with an antibody of unspeciﬁed origin but
claimed to speciﬁcally recognize XCR1 (Artyomov et al., 2015). Howev-
er, the signal-to-noise ratio of that antibody staining on SK_CD141+_-
DDC_B was very poor, and a similar staining was observed on
SK_CD14+_DMPs. Hence, the proposed interpretation that XCR1 may
not faithfully mark the cross-presenting DC subset in human will need
further rigorous experimental testing (Artyomov et al., 2015).
Fluorescently-labeled recombinant human XCL1 or XCL2, the ligands
for XCR1, speciﬁcally stain this receptor on human or monkey XCR1+
DCs and do not stain any of the other cell types examined (Balan et al.,
2014; Dutertre et al., 2014a), but they are not commercially available.
An additional cell surface antigen that could be exploited in identifying
human CD141highXCR1+ dermal DCs is CD11c, because it is expressed at
lower levels on these cells as compared to other cDCs, MoDCs and even
macrophages (Haniffa et al., 2012). This observation is also recapitulat-
ed on in vitro differentiated CD141highXCR1+ DCs from CD34+ cord
blood progenitors (Balan et al., 2014). Other antigens such as BTLA,
CADM1 or CLEC9A should be used in addition to HLA-DR, CD141,
CD11c and negativity for CD14 in characterizing CD141highXCR1+ DCs
(Vu Manh et al., 2015a). The gating strategy we designed and reported
when we ﬁrst identiﬁed human CD141high DDCs (Haniffa et al., 2012)
was not taken into accountwhen others later attempted to identify, pu-
rify and study these same cells (Artyomov et al., 2015; Chu et al., 2012).
In addition to a rigorous isolation strategy, additional a posteriori
analysesmust be performed to authenticate the identity of the cell pop-
ulation isolated, independently of the antigens used for their phenotyp-
ic identiﬁcation. This can include analysis of their gene expression
proﬁles by microarrays, focused qRT–PCR assays or RNA-Seq, compar-
ing the isolated population with internal positive and negative control
populations isolated simultaneously (e.g. other skin MP subsets as
well as blood DC subsets), and/or in comparison with existing MP sub-
set transcriptome datasets in publicly available repositories. The micro-
array transcriptome analysis performed in Artyomov et al. relied on a
limited number of MP subsets as comparator populations, with major
differences in MP subset composition between the human skin versus
mouse datasets and between the human skin versus blood datasets.
The mouse dataset used was restricted to mouse CDP-derived DCs and
to LCs, without inclusion of monocytes, macrophages or monocyte-
derived DCs. In contrast, the human skin dataset used turned out to
only encompass monocyte-derived cells and LCs, without inclusion of
any CDP-derived DCs. Hence, the gene modules generated through theanalyses of these mouse versus human datasets could not be rigorously
mapped across species, including for LCs since the reference MP subset
populations used to generate the LC-speciﬁc signatures are completely
different between the two species studied. Speciﬁcally, the design of
the compendia analyzed by Artyomov et al. led to biasing the human
LC genemodule for enrichment in genes highly expressed in DC subsets
as compared tomonocytes/macrophages, and conversely for themouse
LC gene module which was enriched in genes highly expressed in
monocytes/macrophages as compared to DC subsets (Fig. S9). A similar
problem occurred for the comparison between the human blood versus
skin datasets. Surprisingly, the authors of this study (Artyomov et al.,
2015) did not directly compare the gene expression proﬁles of their der-
mal ‘CD141+ DCs’ with the dermal CD141high DC population reported
previously (Haniffa et al., 2012). It is unclear why in their analysis
Artyomov et al. used only the blood MP from Haniffa et al. but
disregarded the skin MP transcriptome data from the same study. In
our study, we have tried to match as well as possible the human skin,
human blood and mouse compendia. In addition, because eachmethod
of gene expression proﬁling has its own drawbacks and biases, we used
different complementary methods to answer our questions, not only
module analysis using BubbleGUM but also PCA and hierarchical clus-
tering. This ensured robust interpretation of the results.
We do concur with Artyomov et al., that i) LCs transcriptionally re-
semble CDP-derived DCs rather than monocyte-derived cells, ii)
human but not mouse LCs are enriched in genes linked to MHC-I
(cross)-presentation when compared to other monocyte-derived cells,
and iii) mouse and human LCs harbor striking differences in their
gene expression programs, possibly to a larger extent than other pairs
of homologous mouse and human MP subsets. However, our two
main ﬁndings are contrary to the recent report by Artyomov et al.,
since we demonstrate that i) human bona ﬁde CD141high DDCs are
equivalent to blood CD141high DCs and homologous to mouse XCR1+
DCs, and ii) human and mouse LCs are homologous.
Bulk population transcriptomics analysis has enabled enormous
progress in the classiﬁcation and functional interrogation of MPs. How-
ever, our study illustrates the critical need for a rigorous design of gene
expression compendia in order to accuratelymap cell populations or bi-
ological pathways across tissues or species, which requires using com-
prehensive datasets as tightly matched as possible across tissue and
species for their cell type contents. In addition, our study also highlights
the important need for accurate a priori deﬁnition of populations during
sampling of biological material for RNA extraction, and the need for a
posteriori analyses to authenticate the identity of the cell populations
isolated such as to determine if the sampling procedure was accurate
or needs to be changed (Vu Manh et al., 2015a). In our own studies of
MP subsets from pig and sheep, the three-step strategy above allowed
us to identify that the cells we had isolated as putative pig homolog of
human CD1c+ cDCs were not CDP-derived DCs but cells of themonocy-
tic lineage and most likely pig ncMo (Vu Manh et al., 2015b). We antic-
ipate that new unbiased strategies using single-cell transcriptome and
proteome analyses will circumvent some of the difﬁculties with bulk-
population studies and provide the resolution todissect the heterogene-
ity of MP subsets that underpins the breadth and speciﬁcity of immune
responses.
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